Thrombocytopenia and low-dose heparin.
We present two cases in which thrombocytopenia developed during low-dose heparin therapy. They seem to represent the spectrum of heparin-associated thrombocytopenia described by Carreras. Because of the increasing use of low-dose heparin for thromboembolism prophylaxis, and because patient reexposure to heparin is not uncommon, the identification of even a modest fall in platelet count in association with heparin therapy is important.
D000368:Aged; D001281:Atrial Fibrillation / Q000628:therapy; D003097:Collateral Circulation; D004077:Digoxin / Q000627:therapeutic use; D004554:Electric Countershock; D005260:Female; D006493:Heparin / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D010976:Platelet Count; D013921:Thrombocytopenia / Q000139:chemically induced*; D013927:Thrombosis / Q000517:prevention & control; D013997:Time Factors
D004077:Digoxin; D006493:Heparin